Topical NSAID exposure reference · APA 7
Reviewed 2026-10-23

Coșovanu, E.-O., Coșovanu, E.-T., Balan, T. A., Foia, C. I., Tarțău, C. G., Lunguleac, T., Stana, A.-B., Petroaie, A. D., Giușcă, S. E., Coman, E. A., Socolov, D., Balan, R. A., Ursu, R. G., Căruntu, I.-D., & Mititelu-Tarțău, L. (2026). Renal safety of topical diclofenac in adults with increased renal risk: A systematic review. Medicina, 62(8), Article 1606. https://doi.org/10.3390/medicina62081606

Department of Veterans Affairs & Department of Defense. (2025). VA/DoD clinical practice guideline for the primary care management of chronic kidney disease (Version 5.0). https://healthquality.va.gov/HEALTHQUALITY/guidelines/CD/ckd/CKD-CPG_2025-Guideline_final_20250509.pdf

Dowling, T. C., Arjomand, M., Lin, E. T., Allen, L. V., Jr., & McPherson, M. L. (2004). Relative bioavailability of ketoprofen 20% in a poloxamer-lecithin organogel. American Journal of Health-System Pharmacy, 61(23), 2541–2544. https://doi.org/10.1093/ajhp/61.23.2541

Feldmann, R. J., & Maibach, H. I. (1967). Regional variation in percutaneous penetration of 14C cortisol in man. Journal of Investigative Dermatology, 48(2), 181–183. https://doi.org/10.1038/jid.1967.29

Flouvat, B., Roux, A., & Delhotal-Landes, B. (1989). Pharmacokinetics of ketoprofen in man after repeated percutaneous administration. Arzneimittelforschung, 39(7), 812–815. https://pubmed.ncbi.nlm.nih.gov/2783185/

Haleon Canada ULC. (2026a, April 10). Voltaren Emulgel: Diclofenac diethylamine gel, 11.6 mg/g (1.16% w/w) [Product monograph; includes Back & Muscle Pain, Joint Pain Regular Strength, and Active]. https://pdf.hres.ca/dpd_pm/00084235.PDF

Haleon Canada ULC. (2026b, March 30). Voltaren Emulgel Extra Strength and Voltaren Emulgel Joint Pain Extra Strength: Diclofenac diethylamine gel, 23.2 mg/g (2.32% w/w) [Product monograph]. https://pdf.hres.ca/dpd_pm/00084171.PDF

Holt, R. J., Taiwo, T., & Kent, J. D. (2015). Bioequivalence of diclofenac sodium 2% and 1.5% topical solutions relative to oral diclofenac sodium in healthy volunteers. Postgraduate Medicine, 127(6), 581–590. https://doi.org/10.1080/00325481.2015.1058689

Hui, X., Hewitt, P. G., Poblete, N., Maibach, H. I., Shainhouse, J. Z., & Wester, R. C. (1998). In vivo bioavailability and metabolism of topical diclofenac lotion in human volunteers. Pharmaceutical Research, 15(10), 1589–1595. https://doi.org/10.1023/A:1011911302005

InflaFlex [Product brochure]. (n.d.). https://inflaflex.com/wp-content/uploads/2023/04/InflaFlex-Brochure-1.pdf

Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. (2024). KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International, 105(4S), S117–S314. https://kdigo.org/wp-content/uploads/2024/03/KDIGO-2024-CKD-Guideline.pdf

Kienzler, J.-L., Gold, M., & Nollevaux, F. (2010). Systemic bioavailability of topical diclofenac sodium gel 1% versus oral diclofenac sodium in healthy volunteers. The Journal of Clinical Pharmacology, 50(1), 50–61. https://doi.org/10.1177/0091270009336234

Knight Therapeutics Inc. (2025, November 21). Pennsaid: Diclofenac sodium solution, 1.5% w/w, topical [Product monograph]. https://pdf.hres.ca/dpd_pm/00082534.PDF

Krummel, T., Dimitrov, Y., Moulin, B., & Hannedouche, T. (2000). Acute renal failure induced by topical ketoprofen. BMJ, 320(7227), 93. https://doi.org/10.1136/bmj.320.7227.93

Lim, C. C., Ang, A. T. W., Kadir, H. B. A., Lee, P. H., Goh, B. Q., Harikrishnan, S., Kwek, J. L., Gan, S. S. W., Choo, J. C. J., & Tan, N. C. (2021). Short-course systemic and topical non-steroidal anti-inflammatory drugs: Impact on adverse renal events in older adults with co-morbid disease. Drugs & Aging, 38(2), 147–156. https://doi.org/10.1007/s40266-020-00824-4

Lim, C. C., Tan, N. C., Teo, E. P. S., Kadir, H. B. A., Kwek, J. L., Bee, Y. M., Ang, A. T. W., Teo, S. H., Kaushik, M., Tan, C. S., & Choo, J. C. J. (2022). Non-steroidal anti-inflammatory drugs and risk of acute kidney injury and hyperkalemia in older adults: A retrospective cohort study and external validation of a clinical risk model. Drugs & Aging, 39(1), 75–82. https://doi.org/10.1007/s40266-021-00907-w

Mairinger, S., Kwon, M., Bauer, M., Song, J., Lackner, E., Jorda, A., Bergmann, F., Minichmayr, I. K., Kim, K. Y., Choi, M. S., Shim, J. H., Dueker, S. R., Zeitlinger, M., & Langer, O. (2025). Evaluation of dose linearity in the systemic availability and pharmacokinetics of topically administered diclofenac: A 14C-microdosing study in healthy volunteers. Drug Metabolism and Disposition, 53(7), Article 100091. https://doi.org/10.1016/j.dmd.2025.100091

Rebel Distributors Corp. (2010, December 1). Voltaren—Diclofenac sodium gel [Repackaged prescribing information]. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=137c4e7a-e671-413e-b687-89490ef98974

Roth, S. H., & Fuller, P. (2011). Diclofenac topical solution compared with oral diclofenac: A pooled safety analysis. Journal of Pain Research, 4, 159–167. https://doi.org/10.2147/JPR.S20965

Roth, S. H., & Fuller, P. (2012). Pooled safety analysis of diclofenac sodium topical solution 1.5% (w/w) in the treatment of osteoarthritis in patients aged 75 years or older. Clinical Interventions in Aging, 7, 127–137. https://doi.org/10.2147/CIA.S30884

Shainhouse, J. Z., Grierson, L. M., & Naseer, Z. (2010). A long-term, open-label study to confirm the safety of topical diclofenac solution containing dimethyl sulfoxide in the treatment of the osteoarthritic knee. American Journal of Therapeutics, 17(6), 566–576. https://doi.org/10.1097/MJT.0b013e3181d169b5

Teo, S. H., Tan, N. C., Choo, J. C. J., Kwek, J. L., Kadir, H. B. A., Bee, Y. M., Huang, H., Kaushik, M., Ang, A. T. W., & Lim, C. C. (2023). Non-steroidal anti-inflammatory drugs in chronic kidney disease and risk of acute adverse kidney events according to route of administration. International Urology and Nephrology, 55(3), 679–686. https://doi.org/10.1007/s11255-022-03344-9

Tillomed Laboratories Ltd. (2023, May 26). Tiloket (ketoprofen) 2.5% gel [Summary of product characteristics]. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/11854/smpc